Opinion / A Changing View of Sales in Pharma
New approaches to pharma sales: Marrying data analytics with the art of personal engagement The lock-down impact for COVID-19 was stark, looking at available March data cuts from IQVIA…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
News Roundup / China Pharma July 24th 2020
A roundup of latest news from Chinese pharma and biotech, including a record high share price for Hansoh, strategic healthcare partnerships, venture capital gains, and recent IPO news from Sunshine…
COVID-19 / Medicines for Europe Leadership Team on Generics Industry Response & European Pharma Reform
In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European generics, biosimilar and value-added-medicines industry, highlighted their members’ rapid response…
Opinion / US Prescription Drug Pricing: “The Times They Are A Changin”
Ulrich Neumann examines the debate around drug pricing in the US and why it is not going away any time soon. Come senators, congressmen Please heed the call Don’t…
Opinion / The End of “Digital” as a Story of Value
John G. Singer examines why technological solutions are not a quick fix to overcoming the COVID-19 crisis and how a systems shift is crucial to securing better health outcomes in…
Roche / Back on Top of The Global Biopharma Rankings
Swiss giant Roche tops Pharmaceutical Executive’s 2020 list of the world’s biggest pharma companies, up from second place in 2019 and third in 2018. Though its best-selling drugs are soon…
Precision Medicine / Reclaiming Asia's Genomic Destiny
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome sequence is probably one of the most significant landmarks in humanity’s…
China / Boehringer Ingelheim Creates New External Innovation Hub
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma giant Boehringer Ingelheim is taking a step further toward accessing innovation from the…
Opinion / The Case for an Algerian FDA in the Wake of Unethical TV Ads
In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the COVID-19 crisis, regular PharmaBoardroom contributor Yacine Sellam argues for the need for…
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA)…
News Roundup / Algeria Pharma July 2020
Below we present recent news from Algeria’s pharmaceutical industry, including the creation of a dedicated Ministry to boost the sector, changes to the advertising rules for dietary supplements, and local…